GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ectin Research AB (XSAT:ECTIN B) » Definitions » YoY EBITDA Growth

Ectin Research AB (XSAT:ECTIN B) YoY EBITDA Growth : 12.20% (As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Ectin Research AB YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Ectin Research AB's YoY EBITDA Growth for the quarter that ended in Mar. 2024 was 12.20%.

Ectin Research AB's EBITDA per Share for the three months ended in Mar. 2024 was kr-0.18.

Ectin Research AB YoY EBITDA Growth Historical Data

The historical data trend for Ectin Research AB's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ectin Research AB YoY EBITDA Growth Chart

Ectin Research AB Annual Data
Trend Aug19 Aug20 Dec22 Dec23
YoY EBITDA Growth
- -118.60 -1,015.96 -29.17

Ectin Research AB Quarterly Data
Aug19 Aug20 Mar21 Sep21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -22.75 61.68 52.12 -242.19 12.20

Ectin Research AB YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Ectin Research AB's YoY EBITDA Growth for the fiscal year that ended in Dec. 2023 is calculated as:

YoY EBITDA Growth (A: Dec. 2023 )
=(EBITDA per Share (A: Dec. 2023 )-EBITDA per Share (A: Dec. 2022 ))/ | EBITDA per Share (A: Dec. 2022 ) |
=(-1.355--1.049)/ | -1.049 |
=-29.17 %

Ectin Research AB's YoY EBITDA Growth for the quarter that ended in Mar. 2024 is calculated as:

YoY EBITDA Growth (Q: Mar. 2024 )
=(EBITDA per Share (Q: Mar. 2024 )-EBITDA per Share (Q: Mar. 2023 )) / | EBITDA per Share (Q: Mar. 2023 )) |
=(-0.18--0.205)/ | -0.205 |
=12.20 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ectin Research AB YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Ectin Research AB's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Ectin Research AB Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ectin Research AB (XSAT:ECTIN B) » Definitions » YoY EBITDA Growth
Comparable Companies
OSTO:QUIA XSAT:EUCI OSTO:LIDDS OSTO:PROMO OSTO:CLINE B OSTO:AMNI OSTO:REDW XSAT:ALTE OSTO:PHARM OSTO:DIABIO OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX
Traded in Other Exchanges
N/A
Address
Pepparedsleden 1, Molndal, SWE, 431 83
Website
https://www.ectinresearch.com
Ectin Research AB is a pharmaceutical company developing a novel treatment that eliminates cancer tumors. Its drug candidate MFA-370 engages in the treatment of metastatic bladder cancer, and has also shown potential in other cancers such as breast, colorectal and prostate cancer cells.

Ectin Research AB Headlines

No Headlines